Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF, 2564K) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Trouw, L. A. Articles by Blom, A. M. Search for Related Content PubMed PubMed Citation Articles by Trouw, L. A. Articles by Blom, A. M. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Compound via MeSH Substance via MeSH Related Collections Related Article Social Bookmarking                            What's this?

¹ Department of Laboratory Medicine, University Hospital Malmö, Lund University, S-205 02 Malmö, Sweden
² Department of Clinical Sciences, University Hospital Malmö, Lund University, S-205 02 Malmö, Sweden

CORRESPONDENCE Anna M. Blom: Anna.Blom{at}med.lu.se

After cell death, via apoptosis or necrosis, the uptake of dead cells by neighboring cells or phagocytes prevents the release of intracellular content. An array of molecules, including initiation molecules of the complement system, are involved in marking dead cells for uptake. After binding of these molecules, complement activation takes place, which when uncontrolled might result in a proinflammatory state. In the current study we demonstrate that complement inhibitor, C4b-binding protein (C4BP), binds strongly to necrotic cells, irrespective of the cell type used or the method of induction. After binding of the C4BP–protein S (PS) complex to necrotic cells via PS-phosphatidylserine and C4BP-DNA interactions, C4BP-PS inhibits complement activation on these cells. C4BP binds DNA via a patch of positively charged amino acids, mainly on the second complement control domain of the C4BP -chain (affinity constant: 190 nM). Furthermore, C4BP limits DNA release from necrotic cells and inhibits DNA-mediated complement activation in solution. The C4BP–necrotic cell interaction also occurs in vivo as necrotic areas of arteriosclerotic plaques and of various cancers stain strongly positive for C4BP. This study describes a novel mechanism in which C4BP limits the inflammatory potential of necrotic cells.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

C4BP runs damage control

Heather L. Van Epps
J. Exp. Med. 2005 201: 1866. [Full Text] [PDF]

This article has been cited by other articles:

• Happonen, K. E., Sjoberg, A. P., Morgelin, M., Heinegard, D., Blom, A. M. (2009). Complement Inhibitor C4b-Binding Protein Interacts Directly with Small Glycoproteins of the Extracellular Matrix. J. Immunol. 182: 1518-1525 [Abstract] [Full Text]  
• Blom, A M, Nandakumar, K S, Holmdahl, R (2009). C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice. Ann Rheum Dis 68: 136-142 [Abstract] [Full Text]  
• Xu, W., Berger, S. P., Trouw, L. A., de Boer, H. C., Schlagwein, N., Mutsaers, C., Daha, M. R., van Kooten, C. (2008). Properdin Binds to Late Apoptotic and Necrotic Cells Independently of C3b and Regulates Alternative Pathway Complement Activation. J. Immunol. 180: 7613-7621 [Abstract] [Full Text]  
• Blom, A. M., Bergstrom, F., Edey, M., Diaz-Torres, M., Kavanagh, D., Lampe, A., Goodship, J. A., Strain, L., Moghal, N., McHugh, M., Inward, C., Tomson, C., Fremeaux-Bacchi, V., Villoutreix, B. O., Goodship, T. H. J. (2008). A Novel Non-Synonymous Polymorphism (p.Arg240His) in C4b-Binding Protein Is Associated with Atypical Hemolytic Uremic Syndrome and Leads to Impaired Alternative Pathway Cofactor Activity. J. Immunol. 180: 6385-6391 [Abstract] [Full Text]  
• Maurissen, L. F. A., Thomassen, M. C. L. G. D., Nicolaes, G. A. F., Dahlback, B., Tans, G., Rosing, J., Hackeng, T. M. (2008). Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation. Blood 111: 3034-3041 [Abstract] [Full Text]  
• Trouw, L. A., Bengtsson, A. A., Gelderman, K. A., Dahlback, B., Sturfelt, G., Blom, A. M. (2007). C4b-binding Protein and Factor H Compensate for the Loss of Membrane-bound Complement Inhibitors to Protect Apoptotic Cells against Excessive Complement Attack. J. Biol. Chem. 282: 28540-28548 [Abstract] [Full Text]  
• Sjoberg, A. P., Trouw, L. A., Clark, S. J., Sjolander, J., Heinegard, D., Sim, R. B., Day, A. J., Blom, A. M. (2007). The Factor H Variant Associated with Age-related Macular Degeneration (His-384) and the Non-disease-associated Form Bind Differentially to C-reactive Protein, Fibromodulin, DNA, and Necrotic Cells. J. Biol. Chem. 282: 10894-10900 [Abstract] [Full Text]  
• Sjoberg, A. P., Trouw, L. A., McGrath, F. D. G., Hack, C. E., Blom, A. M. (2006). Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of c4b-binding protein.. J. Immunol. 176: 7612-7620 [Abstract] [Full Text]  
• Jenkins, H. T., Mark, L., Ball, G., Persson, J., Lindahl, G., Uhrin, D., Blom, A. M., Barlow, P. N. (2006). Human C4b-binding Protein, Structural Basis for Interaction with Streptococcal M Protein, a Major Bacterial Virulence Factor. J. Biol. Chem. 281: 3690-3697 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS